citric acid, anhydrous has been researched along with isoxazoles in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mousa, SA; Olson, RE; Tobin, AE; Wexler, RR; Wityak, J | 1 |
| Bozarth, JM; Forsythe, MS; Mousa, SA; Slee, A | 1 |
2 other study(ies) available for citric acid, anhydrous and isoxazoles
| Article | Year |
|---|---|
Isoxazoline GPIIb/IIIa antagonists bearing a phosphoramidate.
Topics: Animals; Blood Platelets; Calcium; Citric Acid; Dogs; Drug Design; Heparin; Humans; Inhibitory Concentration 50; Isoxazoles; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex | 1999 |
Differential antiplatelet efficacy for various GPIIb/IIIa antagonists: role of plasma calcium levels.
Topics: Abciximab; Alanine; Amidines; Analysis of Variance; Antibodies, Monoclonal; Anticoagulants; Blood Platelets; Calcium; Citric Acid; Eptifibatide; Fibrinogen; Heparin; Humans; Immunoglobulin Fab Fragments; Iodine Radioisotopes; Isoxazoles; Peptides; Platelet Activation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Pyrrolidines; Tirofiban; Tyrosine | 2000 |